HilleVax (NASDAQ:HLVX) Issues Quarterly Earnings Results, Misses Estimates By $0.10 EPS

HilleVax (NASDAQ:HLVX) posted its quarterly earnings data on Thursday. The company reported ($0.52) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.42) by ($0.10), reports.

HilleVax Stock Down 1.5 %

HLVX opened at $1.91 on Friday. HilleVax has a 52-week low of $1.55 and a 52-week high of $20.22. The company has a market cap of $95.08 million, a P/E ratio of -0.56 and a beta of 0.78. The company has a 50 day moving average of $1.81 and a two-hundred day moving average of $6.20.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the stock. BML Capital Management LLC purchased a new stake in shares of HilleVax during the third quarter valued at approximately $35,000. EntryPoint Capital LLC bought a new position in shares of HilleVax during the first quarter worth about $80,000. GSA Capital Partners LLP acquired a new position in shares of HilleVax in the 3rd quarter worth approximately $126,000. Tidal Investments LLC acquired a new position in HilleVax in the first quarter worth $207,000. Finally, Maven Securities LTD acquired a new position in shares of HilleVax in the 2nd quarter valued at about $217,000. 86.42% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Separately, HC Wainwright restated a “neutral” rating and issued a $2.00 price target on shares of HilleVax in a report on Monday, August 12th. Six investment analysts have rated the stock with a hold rating, According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $9.20.

HilleVax Company Profile

HilleVax, Inc, a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. It develops HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company was formerly known as MokshaCo, Inc and changed its name to HilleVax, Inc in February 2021.